<HashMap><database>EGA</database><scores/><additional><omics_type>Genomics</omics_type><dataset_type>N/A</dataset_type><full_dataset_link>https://ega-archive.org/datasets/EGAD00001015362</full_dataset_link><sample_count>145</sample_count><description>EGA dataset EGAD00001015362</description><repository>EGA</repository><title>NEOPREDICT-Lung: longitudinal whole exome sequencing of non-small cell lung cancers under immunotherapy</title></additional><is_claimable>false</is_claimable><name>2861f5de-e05d-42a6-a8f7-c935bfab2af7 - samples</name><description>In 43 patients pretreatment tumor biopsies, resected tumors and normal tissue of sufficient quality and quantity were obtained to longitudinally explore the mutational profiles of a comprehensive set of cancer-related genes.
For tumor samples, one to four FFPE sections (10 Ã‚Âµm thickness, number depending on sample size) were lysed for genomic DNA isolation. Isolation was performed semi-automatically on the Maxwell purification system (Maxwell RSC DNA FFPE Kit, AS1450, Promega) as specified by the manufacturer. DNA was eluted in 50 Ã‚Âµl RNase-free water and quantified fluorescently for library preparation using a Qubit 2.0 fluorometer (Life Technology) with its appertaining DNA broad-range assay. Corresponding normal DNA was isolated from blood or PBMCs using routinely available QIAGEN technology. DNA was stored at -20Ã‚Â°C before use. 
Whole-exome sequencing (WES) was performed using the Twist Human Core + RefSeq + Mitochondrial Panel (Twist Bioscience), and 2 x 100 bp fragment sizes were sequenced using a NovaSeq6000 (Illumina). Demultiplexing of sequenced reads was achieved using bcl2fastq (version 2.2).</description><dates><updated>2024-05-06 16:10:50</updated></dates><accession>EGAD00001015362</accession><cross_references><TAXONOMY>9606</TAXONOMY><EGA>EGAC00001003479</EGA><EGA>EGAS00001007753</EGA></cross_references></HashMap>